[Fundamental and clinical studies of cefamandole sodium in children (author's transl)].
D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002435:Cefamandole / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D002437:Cefazolin / Q000494:pharmacology; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D008297:Male; D008582:Meningitis, Aseptic / Q000134:cerebrospinal fluid / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D011014:Pneumonia / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy
D002511:Cephalosporins; D002435:Cefamandole; D002437:Cefazolin